What fans the fire: Insights into mechanisms of inflammation in atherosclerosis and diabetes mellitus

Circulation

Volumn 124, Issue 25, 2011, Pages 2809-2811

  Major, Amy S ^a   Harrison, David G ^a  

^a Department of Medicine and Pharmacology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; TOLL LIKE RECEPTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; DIABETES MELLITUS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ATHEROSCLEROSIS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; MALE; METABOLIC SYNDROME X; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K;

EID: 84055192897     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.070565     Document Type: Review

References (20)

1. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317-325.
2. Mathis D, Shoelson SE. Immunometabolism: an emerging frontier. Nat Rev Immunol. 2011;11:81-83.
3. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S, Mathis D. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009;15:930-939.
4. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, Leong HX, Glassford A, Caimol M, Kenkel JA, Tedder TF, McLaughlin T, Miklos DB, Dosch HM, Engleman EG. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011;17:610-617.
5. Winer S, Paltser G, Chan Y, Tsui H, Engleman E, Winer D, Dosch HM. Obesity predisposes to Th17 bias. Eur J Immunol. 2009;39:2629-2635.
6. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, Freeman MW. Reduced atherosclerosis in Myd88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med. 2004;10:416-421. (Pubitemid 38508522)
7. Gibson FC 3rd, Hong C, Chou HH, Yumoto H, Chen J, Lien E, Wong J, Genco CA. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2004;109: 2801-2806. (Pubitemid 38737928)
8. Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by toll-like receptor. J Clin Invest. 2005;115:3149-3156. (Pubitemid 41567579)
9. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, Moore KJ. Cd36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2010;11:155-161.
10. Hasu M, Thabet M, Tam N, Whitman SC. Specific loss of toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice. Can J Physiol Pharmacol. 2011;89:737-742.
11. Whitman SC, Rateri DL, Szilvassy SJ, Yokoyama W, Daugherty A. Depletion of natural killer cell function decreases atherosclerosis in lowdensity lipoprotein receptor null mice. Arterioscler Thromb Vasc Biol. 2004;24:1049-1054. (Pubitemid 38737830)
12. Whitman SC, Ravisankar P, Daugherty A. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/-mice. J Interferon Cytokine Res. 2002;22:661-670. (Pubitemid 35034524)
13. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med. 2006;12:178-180. (Pubitemid 43214743)
14. Tupin E, Nicoletti A, Elhage R, Rudling M, Ljunggren HG, Hansson GK, Berne GP. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med. 2004;199:417-422. (Pubitemid 38252053)
15. van Puijvelde GH, van Wanrooij EJ, Hauer AD, de Vos P, van Berkel TJ, Kuiper J. Effect of natural killer T cell activation on the initiation of atherosclerosis. Thromb Haemost. 2009;102:223-230.
16. Ketelhuth DF, Hansson GK. Cellular immunity, low-density lipoprotein and atherosclerosis break of tolerance in the artery wall. Thromb Haemost. 2011;106;779-786.
17. Milioti N, Bermudez-Fajardo A, Penichet ML, Oviedo-Orta E. Antigeninduced immunomodulation in the pathogenesis of atherosclerosis. Clin Dev Immunol. 2008;2008:723539.
18. Xia M, Guerra N, Sukhova GK, Yang K, Miller CK, Shi G-P, Raulet DH, Xiong N. Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis. Circulation. 2011;124;2933-2943.
19. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003;3:781-790. (Pubitemid 37328656)
20. Frostegard J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol. 2005;25:1776-1785. (Pubitemid 41243443)